Stay updated on Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2 on the page. This is a versioning update with no changes to study content.
    Difference
    0.1%
    Check dated 2026-04-16T11:06:05.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:59:25.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision banner updated to v3.4.3, replacing the previous v3.4.2 label.
    Difference
    0.1%
    Check dated 2026-03-11T15:53:27.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    A new site revision label 'Revision: v3.4.2' was added, and the notice about government funding lapses was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:16:09.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page adds a government funding lapse notice and NIH/OPM status update, and updates the revision to v3.4.1 (replacing the previous v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T06:53:11.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page adds a glossary toggle, updates and standardizes QC-related labels (Last Update Submitted that Met QC Criteria) and capitalization (No FEAR Act Data), and shows a new revision version (v3.4.0), while removing the older QC label and older revision reference.
    Difference
    0.2%
    Check dated 2026-01-28T04:34:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & ATRA combo in Adv. Melanoma Clinical Trial page.